Vaxart signed Memorandum of Understanding with Attwill Medical Solutions Sterilflow
On Jun. 26, 2020, Vaxart announced that its oral COVID-19 vaccine has been selected to participate in a…
-
-
University of Alberta researcher to test whether COVID-19 antibodies provide long-term immunity
On Jun. 25, 2020, the University of Alberta (U of A) announced a study that will analyze thousands…
-
The FDA approved new therapy for Dravet Syndrome
On Jun. 25, 2020, the U.S. Food and Drug Administration (FDA) approved Fintepla (fenfluramine), a Schedule IV controlled…
-
Government of Canada and provincial partners invested more than $109 mllion in COVID-19 research
On Jun. 25, 2020, the Government of Canada announced the results of that funding competition: an investment of…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Non-Profit Research | Therapeutics | Vaccine
University of British Columbia received $14 million in federal funding for COVID-19 research
On Jun. 25, 2020, researchers at the University of British Columbia announced they had received a combined total…
-
Vaxart signed Memorandum of Understanding with Attwill Medical Solutions Sterilflow
On Jun. 25, 2020, Vaxart announced it had signed a Memorandum of Understanding with Attwill Medical Solutions Sterilflow,…
-
Moderna and Catalent announced collaboration for fill-finish manufacturing of Moderna’s COVID-19 vaccine candidate
On Jun. 25, 2020 Moderna announced a collaboration for large-scale, commercial fill-finish manufacturing of Moderna’s mRNA-based COVID-19 vaccine…
-
Mayo Clinic launched imaging solution to enable digital pathology across the enterprise
On Jun. 25, 2020, in support of Mayo Clinic’s digital health and practice transformation initiatives, the Mayo Clinic…
-
LabCorp launched new neutralizing antibody test
On Jun. 25, 2020, LabCorp announced the launch of a new test that can be used to assess…
-
SIGA Technologies announced deliveries of oral TPOXX to HHS valued at approximately $32 million
On Jun. 25, 2020, SIGA Technologies announced the deliveries of oral TPOXX (tecovirimat) to the U.S. Department of…
-
Biotechnology | Diagnostics | Disease | Neurology | NIH | Therapeutics
Seattle researchers teamed up to build hi-res brain map of Alzheimer’s disease
On Jun. 25, 2020, the Allen Institute announced a new a new $40.5 million collaborative research center in…
-
Sinovac received approval from China for its quadrivalent influenza vaccine
On Jun. 24, 2020, Sinovac Biotech announced the China National Medical Products Administration (NMPA) issued a product license…
-
Mateon selected by IBM Watson Health for use of IBM Clinical Development Solution to support clinical COVID-19 vaccine candidates
On Jun. 24, 2020, Oncotelic, a wholly owned subsidiary of Mateon Therapeutics, announced that IBM has granted access…
-
Texas A&M researchers testing COVID-19 vaccine candidates for iBio
On Jun. 24, 2020, a team of scientists at Texas A&M University announced it is working with iBio…
-
RedHill Biopharma announced data from severe COVID-19 patients showed substantial benefit to patients
On Jun. 24, 2020, RedHill Biopharma announced that results from the treatment of the first severe COVID-19 patients…
-
Why men may fare worse than women against SARS-CoV-2
On Jun. 24, 2020, Howard Hughes Medical Institute (HHMI) investigators reported that data from COVID-19 cases around the…
-
Symbiosis and AstraZeneca signed supply agreement for sterile manufacture of COVID-19 vaccine for clinical trials
On Jun. 24, 2020, Symbiosis Pharmaceutical Services, an India-based specialist provider of pharmaceutical and vaccine development services, announced…
-
New Oxford University co-led platform accelerated COVID-19 tests into real-world use
On Jun. 24, 2020, the University of Oxford that the COVID-19 National DiagnOstic Research and Evaluation Platform (CONDOR)…
-
The FDA announced first of its kind pilot program to communicate patient reported outcomes from cancer clinical trials
On Jun. 23, 2020, the U.S. Food and Drug Administration today launched Project Patient Voice, an initiative of…
-
Universal mosquito vaccine tested
On Jun. 23, 2020, the National Institutes of Health (NIH) announced it had tested a ‘universal mosquito vaccine’…
-
Experts identified steps to expand and improve antibody tests in COVID-19 response
On Jun. 23, 2020, more than 300 scientists and clinicians from the federal government, industry and academia published…
-
FibroGen announced first patient enrolled in Pamrevlumab clinical trial in patients hospitalized in US with acute COVID-19
On Jun. 23, 2020, FibroGen announced it has started enrollment for a Phase II clinical trial of pamrevlumab…
-
Mateon selected IQVIA for its randomized, controlled, multi-menter clinical study to test OT-101 as treatment for COVID-19 patients
On Jun. 23, 2020, Mateon Therapeutics, a leading developer of TGF-β therapeutics, announced it has selected IQVIA to…
-
Flu mutation study suggested universal flu vaccine may be even more challenging than expected
On Jun. 23, 2020, scientists at Scripps Research reported that some common strains of influenza have the potential…
-
Takeda received FDA approval to manufacture ENTYVIO (vedolizumab) drug substance at Brooklyn Park, Minnesota facility
On Jun. 23, 2020, Takeda Pharmaceutical announced that the U.S. Food and Drug Administration (FDA) had approved the…
-
University of Missouri scientists assisting Missouri officials with Coronavirus Sewer shed Surveillance Project
On Jun. 23, 2020, studies in the Netherlands and other places have shown that the presence of SARS-Coronavirus-2,…
-
Sanofi and Translate Bio expanded collaboration and license agreement to develop mRNA vaccines for infectious diseases
On Jun. 23, 2020, Sanofi Pasteur, the vaccines global business unit of Sanofi, and Translate Bio, a clinical-stage…
-
INOVIO received $71 million contract from U.S. Department of Defense to scale up manufacture of CELLECTRA 3PSP smart device
On Jun. 23, 2020, INOVIO announced it had received $71 million funding from the U.S. Department of Defense…
-
Pfizer announced start of four phase 3 clinical trials for investigational vaccines
On Jun. 22, 2020, Pfizer announced the initiation of four phase 3 clinical trials within its current pipeline…
-
Taconic Biosciences announced distribution of critical COVID-19 mouse model
On Jun. 22, 2020, Taconic Biosciences announced an exclusive agreement with the University of Texas Medical Branch at…
